Barry Shin Compass Therapeutics, Inc. (CMPX) insider trading activity

CMPX Quotes by TradingView

Barry Shin is CFO of Compass Therapeutics, Inc.. Currently has a direct ownership of 525,000 shares of CMPX, which is worth approximately $2.56 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 125,000 shares (Common Stock) at a price of $5.17 per share, resulting in proceeds of $646,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 525K
31.25% 3M change
31.25% 12M change
Total Value Held $2.56 Million

Barry Shin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
BUY
Grant, award, or other acquisition
$646,250 $5.17 p/Share
125,000 Added 19.23%
525,000 Common Stock
Dec 09 2024
BUY
Grant, award, or other acquisition
$660,000 $1.65 p/Share
400,000 Added 50.0%
400,000 Common Stock

Also insider at

TRVN
TREVENA INC Healthcare
Acting COO and CFO
BS

Barry Shin

CFO
Chesterbrook, PA

Track Institutional and Insider Activities on CMPX

Follow Compass Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CMPX shares.

Notify only if

Insider Trading

Get notified when an Compass Therapeutics, Inc. insider buys or sells CMPX shares.

Notify only if

News

Receive news related to Compass Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CMPX